Holdings

Sanofi

As of Sep 30, 2026, Sanofi reported 15 positions worth US$566M. Largest: MeiraGTx Holdings plc, Inhibrx Biosciences, Inc. and Novavax, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
MeiraGTx Holdings plc12.2MUS$134Mno changeSep 30, 2026
Inhibrx Biosciences, Inc.1.16MUS$116Mno changeSep 30, 2026
Novavax, Inc.6.88MUS$74.4Mno changeSep 30, 2026
Odyssey Therapeutics, Inc.1.99MUS$44.2M−1,718Sep 30, 2026
AnaptysBio, Inc.822KUS$41.3Mno changeSep 30, 2026
AgomAb Therapeutics NV2.78MUS$30.9MnewSep 30, 2026
First Tracks Biotherapeutics, Inc.822KUS$29.1Mno changeSep 30, 2026
Electra Therapeutics, Inc.2.46MUS$27.7MnewSep 30, 2026
Attovia Therapeutics, Inc.1.08MUS$18.6MnewSep 30, 2026
Latigo Biotherapeutics, Inc.673KUS$11.2MnewSep 30, 2026